"novartis" - Google News

Novartis, amid reorg, cuts ‘select number’ of biomedical research roles - Fierce Biotech

Fri, 15 May 2026 14:58:27 GMT

Novartis, amid reorg, cuts ‘select number’ of biomedical research roles Fierce Biotech

New prostate cancer hopes from Roche and Novartis | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Tue, 12 May 2026 14:32:21 GMT

New prostate cancer hopes from Roche and Novartis | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Novartis to cut 220 jobs as it closes German site - Reuters

Tue, 05 May 2026 07:00:00 GMT

Novartis to cut 220 jobs as it closes German site Reuters

Novartis finalizes new drug manufacturing facility in Morrisville, North Carolina - ABC11 Raleigh-Durham

Thu, 30 Apr 2026 07:00:00 GMT

Novartis finalizes new drug manufacturing facility in Morrisville, North Carolina ABC11 Raleigh-Durham

Novartis Selects Winter Park for New Radioligand Therapy Manufacturing Facility - Orlando Economic Partnership

Wed, 06 May 2026 16:56:27 GMT

Novartis Selects Winter Park for New Radioligand Therapy Manufacturing Facility Orlando Economic Partnership

Novartis pharmaceuticals will expand in NC with Morrisville facility - WRAL

Thu, 30 Apr 2026 07:00:00 GMT

Novartis pharmaceuticals will expand in NC with Morrisville facility WRAL

Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months' - CNBC

Tue, 28 Apr 2026 07:00:00 GMT

Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months' CNBC

Novartis partners with Special Olympics World Winter Games Switzerland 2029 - Novartis

Mon, 04 May 2026 14:35:34 GMT

Novartis partners with Special Olympics World Winter Games Switzerland 2029 Novartis

Pharma giant lays off workers in Emeryville amid plans for centralized West Coast hub - The Business Journals

Fri, 15 May 2026 21:08:00 GMT

Pharma giant lays off workers in Emeryville amid plans for centralized West Coast hub The Business Journals

Novartis rounds out $23B US investment push with plans for North Carolina API plant - Fierce Pharma

Thu, 30 Apr 2026 07:00:00 GMT

Novartis rounds out $23B US investment push with plans for North Carolina API plant Fierce Pharma

Swiss drugmaker Novartis breaks ground on Denton facility - NBC 5 Dallas-Fort Worth

Thu, 07 May 2026 07:00:00 GMT

Swiss drugmaker Novartis breaks ground on Denton facility NBC 5 Dallas-Fort Worth

Stanford Radiology to Collaborate with Novartis to Advance Innovation in Translational Imaging Research - Stanford Medicine

Wed, 17 Dec 2025 08:00:00 GMT

Stanford Radiology to Collaborate with Novartis to Advance Innovation in Translational Imaging Research Stanford Medicine

Implied Volatility Surging for Novartis Stock Options - TradingView

Wed, 13 May 2026 13:03:00 GMT

Implied Volatility Surging for Novartis Stock Options TradingView

Novartis Earnings Hit by Generic Competition - WSJ

Tue, 28 Apr 2026 07:00:00 GMT

Novartis Earnings Hit by Generic Competition WSJ

Novartis sales fall as blockbuster patents expire - Financial Times

Tue, 28 Apr 2026 07:00:00 GMT

Novartis sales fall as blockbuster patents expire Financial Times

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs - CNBC

Mon, 27 Apr 2026 07:00:00 GMT

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs CNBC

⁠Novartis posts earnings miss as generic rivals hurt blockbuster drug Entresto - Reuters

Tue, 28 Apr 2026 07:00:00 GMT

⁠Novartis posts earnings miss as generic rivals hurt blockbuster drug Entresto Reuters

Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies - Fierce Pharma

Tue, 28 Apr 2026 07:00:00 GMT

Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies Fierce Pharma

Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts, but no deals in the works - Fierce Biotech

Tue, 28 Apr 2026 07:00:00 GMT

Novartis CEO ‘continuing to evaluate’ in vivo CAR-Ts, but no deals in the works Fierce Biotech

Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week - CNBC

Fri, 27 Mar 2026 07:00:00 GMT

Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week CNBC

Global pharma company Novartis plans $220-million RTP investment - Spectrum News

Wed, 06 May 2026 15:28:00 GMT

Global pharma company Novartis plans $220-million RTP investment Spectrum News

Novartis stands by $5B Pluvicto goal despite European regulatory setback, bispecific competition - Fierce Pharma

Tue, 28 Apr 2026 07:00:00 GMT

Novartis stands by $5B Pluvicto goal despite European regulatory setback, bispecific competition Fierce Pharma

Novartis pulls bid to broaden Pluvicto use after EU pushback - FirstWord Pharma

Fri, 24 Apr 2026 07:00:00 GMT

Novartis pulls bid to broaden Pluvicto use after EU pushback FirstWord Pharma

Novartis adds another Triangle facility to cap off $23 billion US pharma plan - Raleigh News & Observer

Wed, 06 May 2026 07:00:00 GMT

Novartis adds another Triangle facility to cap off $23 billion US pharma plan Raleigh News & Observer

New long term social impact and sustainability targets - Novartis

Mon, 13 Apr 2026 07:00:00 GMT

New long term social impact and sustainability targets Novartis

Novartis receives European Commission approval for Rhapsido skin disease drug - Reuters

Sun, 26 Apr 2026 07:00:00 GMT

Novartis receives European Commission approval for Rhapsido skin disease drug Reuters

Novartis CEO on Q1 earnings miss - CNBC

Tue, 28 Apr 2026 07:00:00 GMT

Novartis CEO on Q1 earnings miss CNBC

Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial - Fierce Biotech

Wed, 22 Apr 2026 07:00:00 GMT

Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial Fierce Biotech

Novartis, PTC push Huntington’s drug into Phase 3, mum on accelerated approval - BioSpace

Wed, 29 Apr 2026 07:00:00 GMT

Novartis, PTC push Huntington’s drug into Phase 3, mum on accelerated approval BioSpace

Novartis cuts 114 more jobs at New Jersey HQ as restructuring rolls on - Fierce Pharma

Fri, 10 Apr 2026 07:00:00 GMT

Novartis cuts 114 more jobs at New Jersey HQ as restructuring rolls on Fierce Pharma

Desmond (Des) Creary - Novartis

Thu, 23 Oct 2025 19:40:34 GMT

Desmond (Des) Creary Novartis

Exclusive | Anthropic Adds Novartis CEO to Board - WSJ

Tue, 14 Apr 2026 07:00:00 GMT

Exclusive | Anthropic Adds Novartis CEO to Board WSJ

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis - Arrowhead Pharmaceuticals, Inc.

Tue, 21 Oct 2025 07:00:00 GMT

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis Arrowhead Pharmaceuticals, Inc.

Anthropic adds Novartis CEO Vas Narasimhan to its board - Reuters

Tue, 14 Apr 2026 07:00:00 GMT

Anthropic adds Novartis CEO Vas Narasimhan to its board Reuters

Full Circle: A Story of Growth, Purpose and Coming Home to Novartis - Novartis

Tue, 28 Apr 2026 07:00:00 GMT

Full Circle: A Story of Growth, Purpose and Coming Home to Novartis Novartis

ROI Tracking as Mens Rea ? Novartis Ruling Reframes AKS Pleading Risk - Crowell & Moring LLP

Thu, 16 Apr 2026 18:41:08 GMT

ROI Tracking as Mens Rea ? Novartis Ruling Reframes AKS Pleading Risk Crowell & Moring LLP

Novartis CEO joins Anthropic board, embedding AI in the heart of biopharma - BioSpace

Thu, 16 Apr 2026 07:00:00 GMT

Novartis CEO joins Anthropic board, embedding AI in the heart of biopharma BioSpace

Total number of Novartis AG's full-time employees from 2009 to 2025 - Statista

Thu, 19 Feb 2026 08:00:00 GMT

Total number of Novartis AG's full-time employees from 2009 to 2025 Statista

How Novartis is helping to eliminate leprosy - Novartis

Wed, 04 Feb 2026 08:00:00 GMT

How Novartis is helping to eliminate leprosy Novartis

Here's What Analysts Are Forecasting For Novartis AG (VTX:NOVN) After Its First-Quarter Results - Yahoo Finance

Fri, 01 May 2026 07:00:00 GMT

Here's What Analysts Are Forecasting For Novartis AG (VTX:NOVN) After Its First-Quarter Results Yahoo Finance

Global pharmaceutical company plans to invest $771m, expecting to create 700 jobs in Durham and Wake counties - Wake County Government (.gov)

Wed, 19 Nov 2025 08:00:00 GMT

Global pharmaceutical company plans to invest $771m, expecting to create 700 jobs in Durham and Wake counties Wake County Government (.gov)

SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease - PR Newswire

Mon, 12 Jan 2026 08:00:00 GMT

SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease PR Newswire

Entrada's stock craters as DMD data underperform expectations, handing advantage to Novartis - Fierce Biotech

Thu, 07 May 2026 07:00:00 GMT

Entrada's stock craters as DMD data underperform expectations, handing advantage to Novartis Fierce Biotech

Henrietta Lacks’s Family Settles Suit With Novartis Over Use of Her Cells - The New York Times

Fri, 27 Feb 2026 08:00:00 GMT

Henrietta Lacks’s Family Settles Suit With Novartis Over Use of Her Cells The New York Times

Novartis sharpening India strategy as a pure-play innovator - The Economic Times

Thu, 14 May 2026 07:00:00 GMT

Novartis sharpening India strategy as a pure-play innovator The Economic Times

Novartis’ biomedical research head on AI, pruning the pipeline, and a potential blockbuster - statnews.com

Wed, 11 Feb 2026 08:00:00 GMT

Novartis’ biomedical research head on AI, pruning the pipeline, and a potential blockbuster statnews.com

Novartis sees sales boost from key cancer drugs - CNBC

Thu, 20 Nov 2025 08:00:00 GMT

Novartis sees sales boost from key cancer drugs CNBC

Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen - Fierce Pharma

Wed, 15 Apr 2026 07:00:00 GMT

Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen Fierce Pharma

Novartis pays $2B to land a startup’s breast cancer drug - BioPharma Dive

Fri, 20 Mar 2026 07:00:00 GMT

Novartis pays $2B to land a startup’s breast cancer drug BioPharma Dive

Novartis to buy experimental breast cancer drug in up to $3 billion deal - Reuters

Fri, 20 Mar 2026 07:00:00 GMT

Novartis to buy experimental breast cancer drug in up to $3 billion deal Reuters

Novartis in San Diego: A Quarter Century of R&D Innovation - Novartis

Thu, 21 Aug 2025 07:00:00 GMT

Novartis in San Diego: A Quarter Century of R&D Innovation Novartis

Novartis Earnings: Strong Momentum in Growth Products Offset by Entresto's Generic Erosion - Morningstar Canada

Wed, 29 Apr 2026 07:00:00 GMT

Novartis Earnings: Strong Momentum in Growth Products Offset by Entresto's Generic Erosion Morningstar Canada

Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices - Fierce Pharma

Wed, 25 Mar 2026 07:00:00 GMT

Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices Fierce Pharma

Novartis, Genentech file suit alleging illegal importation of prescription drug - CNBC

Thu, 26 Feb 2026 08:00:00 GMT

Novartis, Genentech file suit alleging illegal importation of prescription drug CNBC

Five Questions with Reshema Kemps-Polanco, Novartis US Chief Commercial Officer - Novartis

Fri, 29 Aug 2025 13:54:43 GMT

Five Questions with Reshema Kemps-Polanco, Novartis US Chief Commercial Officer Novartis

Novartis unveils North Carolina API plant as final piece of $23B US expansion - BioSpace

Fri, 01 May 2026 07:00:00 GMT

Novartis unveils North Carolina API plant as final piece of $23B US expansion BioSpace

Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D - Fierce Pharma

Mon, 23 Mar 2026 07:00:00 GMT

Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D Fierce Pharma

Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca - BioSpace

Tue, 24 Mar 2026 07:00:00 GMT

Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca BioSpace

Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion - WSJ

Fri, 27 Mar 2026 07:00:00 GMT

Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion WSJ

Novartis seeks to deepen India innovation play - The Times of India

Wed, 13 May 2026 12:50:00 GMT

Novartis seeks to deepen India innovation play The Times of India

Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle - Fierce Biotech

Fri, 20 Mar 2026 07:00:00 GMT

Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle Fierce Biotech

Nearly 300 N.J. healthcare layoffs: Novartis, Labcorp among companies cutting jobs - NJ.com

Sat, 04 Apr 2026 07:00:00 GMT

Nearly 300 N.J. healthcare layoffs: Novartis, Labcorp among companies cutting jobs NJ.com

Novartis to pay up to $2 billion for US biotech firm Excellergy - Reuters

Fri, 27 Mar 2026 07:00:00 GMT

Novartis to pay up to $2 billion for US biotech firm Excellergy Reuters

Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal - Fierce Biotech

Wed, 18 Feb 2026 08:00:00 GMT

Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal Fierce Biotech

Novartis’ U.S. deal could shield it from tariffs, CEO tells CNBC - CNBC

Tue, 20 Jan 2026 08:00:00 GMT

Novartis’ U.S. deal could shield it from tariffs, CEO tells CNBC CNBC

Novartis to exit India unit in $159 mln deal; Mumbai-listed shares surge 20% - Reuters

Fri, 20 Feb 2026 08:00:00 GMT

Novartis to exit India unit in $159 mln deal; Mumbai-listed shares surge 20% Reuters

Novartis to build manufacturing hub in North Carolina, creating 700 jobs - Reuters

Wed, 19 Nov 2025 08:00:00 GMT

Novartis to build manufacturing hub in North Carolina, creating 700 jobs Reuters

Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement - Arrowhead Pharmaceuticals, Inc.

Tue, 02 Sep 2025 07:00:00 GMT

Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement Arrowhead Pharmaceuticals, Inc.

Ethos rejects Novartis CEO, management pay as excessive - Reuters

Tue, 24 Feb 2026 08:00:00 GMT

Ethos rejects Novartis CEO, management pay as excessive Reuters

With Texas site, Novartis rounds out radiopharma production plans amid $23B US investment blitz - Fierce Pharma

Wed, 25 Feb 2026 08:00:00 GMT

With Texas site, Novartis rounds out radiopharma production plans amid $23B US investment blitz Fierce Pharma

Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates - Fierce Biotech

Wed, 04 Feb 2026 08:00:00 GMT

Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates Fierce Biotech

Novartis perseveres with pelabresib | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Mon, 26 Jan 2026 08:00:00 GMT

Novartis perseveres with pelabresib | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Novartis pens $2B deal for allergy biotech with potential Xolair successor - Fierce Biotech

Fri, 27 Mar 2026 07:00:00 GMT

Novartis pens $2B deal for allergy biotech with potential Xolair successor Fierce Biotech

Novartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy - BioSpace

Thu, 05 Feb 2026 08:00:00 GMT

Novartis Cuts 6 Early Cancer Candidates, Adds 2 to Refine Oncology Strategy BioSpace

Novartis Drops $1.7 Billion on AI Allergy Breakthrough - Yahoo Finance

Tue, 09 Dec 2025 08:00:00 GMT

Novartis Drops $1.7 Billion on AI Allergy Breakthrough Yahoo Finance

Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine - AP News

Thu, 26 Feb 2026 08:00:00 GMT

Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine AP News

Novartis and UK-based Relation forge R&D deal worth up to $1.7bn - Pharmaceutical Technology

Thu, 11 Dec 2025 08:00:00 GMT

Novartis and UK-based Relation forge R&D deal worth up to $1.7bn Pharmaceutical Technology

Novartis AG stock (CH0012005267): dividend profile and pipeline focus move into the spotlight - AD HOC NEWS

Sat, 16 May 2026 13:20:58 GMT

Novartis AG stock (CH0012005267): dividend profile and pipeline focus move into the spotlight AD HOC NEWS

Novartis to buy U.S. biotech firm Avidity Biosciences for about $12 billion in cash - CNBC

Sun, 26 Oct 2025 07:00:00 GMT

Novartis to buy U.S. biotech firm Avidity Biosciences for about $12 billion in cash CNBC

NC sues drugmaker Novartis for price-fixing, along with most other states - WRAL

Tue, 03 Feb 2026 08:00:00 GMT

NC sues drugmaker Novartis for price-fixing, along with most other states WRAL

Unnatural Products, Novartis sign licensing agreement for cardiovascular program - Reuters

Wed, 18 Feb 2026 08:00:00 GMT

Unnatural Products, Novartis sign licensing agreement for cardiovascular program Reuters

Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion - WSJ

Fri, 20 Mar 2026 07:00:00 GMT

Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion WSJ

JPM26: Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos - BioSpace

Tue, 13 Jan 2026 08:00:00 GMT

JPM26: Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos BioSpace

Novartis winds down ph. 1 solid tumor program after lacking efficacy - Fierce Biotech

Thu, 19 Feb 2026 08:00:00 GMT

Novartis winds down ph. 1 solid tumor program after lacking efficacy Fierce Biotech

Designing for the Future: The Next Era of Biomedical Research in San Diego - Novartis

Thu, 21 Aug 2025 07:00:00 GMT

Designing for the Future: The Next Era of Biomedical Research in San Diego Novartis

Novartis misses quarterly sales, profit estimates as Entresto generics hit growth - Yahoo Finance

Tue, 28 Apr 2026 07:00:00 GMT

Novartis misses quarterly sales, profit estimates as Entresto generics hit growth Yahoo Finance

Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech - Fierce Biotech

Tue, 09 Dec 2025 08:00:00 GMT

Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech Fierce Biotech

Novartis CEO projects 2026 growth despite ‘largest patent expiry’ in company history - Fierce Pharma

Wed, 04 Feb 2026 08:00:00 GMT

Novartis CEO projects 2026 growth despite ‘largest patent expiry’ in company history Fierce Pharma

Novartis plots sale of India unit while maintaining separate commercial, R&D business in country - Fierce Pharma

Fri, 20 Feb 2026 08:00:00 GMT

Novartis plots sale of India unit while maintaining separate commercial, R&D business in country Fierce Pharma

Novartis opens new plant in California to make cancer drugs - Reuters

Mon, 10 Nov 2025 08:00:00 GMT

Novartis opens new plant in California to make cancer drugs Reuters

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG - PR Newswire

Sun, 26 Oct 2025 07:00:00 GMT

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG PR Newswire

Novartis shares fall as generics dent blockbuster heart drug - Reuters

Mon, 27 Oct 2025 07:00:00 GMT

Novartis shares fall as generics dent blockbuster heart drug Reuters

Novartis expects to eliminate US tariff exposure by mid‑2026, CEO tells CNBC - Reuters

Tue, 20 Jan 2026 08:00:00 GMT

Novartis expects to eliminate US tariff exposure by mid‑2026, CEO tells CNBC Reuters

Novartis flags 2026 profit drop as patents for key drugs expire - Reuters

Wed, 04 Feb 2026 08:00:00 GMT

Novartis flags 2026 profit drop as patents for key drugs expire Reuters

Novartis dives deeper into protein degraders with second Monte Rosa deal - BioPharma Dive

Mon, 15 Sep 2025 07:00:00 GMT

Novartis dives deeper into protein degraders with second Monte Rosa deal BioPharma Dive

Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff - Pharmaceutical Executive

Wed, 04 Feb 2026 08:00:00 GMT

Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff Pharmaceutical Executive

Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program - Business Wire

Fri, 20 Mar 2026 07:00:00 GMT

Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program Business Wire

Novartis charts next US investment with plan for new radiopharma plant in Florida - Fierce Pharma

Fri, 09 Jan 2026 08:00:00 GMT

Novartis charts next US investment with plan for new radiopharma plant in Florida Fierce Pharma

Governor Stein Celebrates Novartis Groundbreaking and Expansion in the Research Triangle - NC Governor (.gov)

Thu, 11 Dec 2025 08:00:00 GMT

Governor Stein Celebrates Novartis Groundbreaking and Expansion in the Research Triangle NC Governor (.gov)